CAH - Cardinal Health Inc - SEC Form 4 Insider Trading Screener

Retail Trade - Nondurable Goods - Wholesale-drugs, Proprietaries & Druggists' Sundries - CAH (721371)
Filing Date
  
Trade Date
  
Tickers
Insider Name
Trade Type
Share Price $
Value Traded $
Officer
   CEO
   CFO
Director
10% Owner
Other
SIC Industry
Sort by
Max Results
Exclude derivative-related
clear
500 results for CAH - Yahoo - Tradingview - Stocktwits - SEC

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2015-11-30
CAHWatkins Carole SCHROF - Tax$86.85-28633,971-1%-$24,839-1000
2015-11-30
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.G - Gift$0.00-1,17832,455-4%-$0-2000
2015-11-15
CAHMorford Craig SChief Legal, Compliance OfficeA - Grant$0.00+9,35791,177+11%+$0+2000
2015-11-17
CAHFitzgerald MeghanEVP, Strategy, Health PolicyF - Tax$86.19-26016,760-2%-$22,409+2000
D
2015-11-10
CAHBarrett George SCOB, CEOM - OptEx$27.29+54,658406,134+16%+$1,491,617-2+2-20
D
2015-11-10
CAHBarrett George SCOB, CEOS - Sale+OE$87.73-54,658406,134-12%-$4,795,146-2+2-20
D
2015-08-28
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.G - Gift$0.00-7533,6330%-$00-200
D
2015-11-06
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.M - OptEx$51.94+30,08533,633+848%+$1,562,7230-200
D
2015-11-06
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$87.66-30,08533,633-47%-$2,637,2510-200
2015-11-04
CAHArnold Colleen F.DirA - Grant$0.00+1,84823,445+9%+$00-3+10
2015-11-04
CAHKing David PDirA - Grant$0.00+1,84815,974+13%+$00-3+10
2015-11-04
CAHAnderson David JDirA - Grant$0.00+1,8485,276+54%+$00-3+10
2015-11-04
CAHHall Patricia HemingwayDirA - Grant$0.00+1,8486,488+40%+$00-3+10
2015-11-04
CAHJones Clayton MDirA - Grant$0.00+1,8489,894+23%+$00-3+10
2015-11-04
CAHDarden CalvinDirA - Grant$0.00+1,84824,619+8%+$00-3+10
2015-11-04
CAHKillefer NancyDirA - Grant$0.00+1,8481,848New+$00-3+10
2015-11-04
CAHCox Carrie SmithDirA - Grant$0.00+1,84820,617+10%+$00-3+10
2015-11-04
CAHKenny Gregory BDirA - Grant$0.00+2,07923,944+10%+$00-3+10
2015-11-04
CAHDowney BruceDirA - Grant$0.00+1,84832,915+6%+$00-3+10
2015-09-15
CAHKaufmann Michael CCFOF - Tax$84.31-6,330159,758-4%-$533,682+1-5-40
2015-09-15
CAHGiacomin Jon LCEO, Pharmaceutical SegmentF - Tax$84.31-84426,300-3%-$71,158+1-5-40
2015-09-01
CAHKaufmann Michael CCFOF - Tax$82.27-8,770166,088-5%-$721,508-1+2-30
D
2015-08-20
CAHBarrett George SCOB, CEOM - OptEx$27.29+300,000406,134+283%+$8,187,000-2+2+10
D
2015-08-20
CAHBarrett George SCOB, CEOS - Sale+OE$83.08-300,000406,134-42%-$24,924,000-2+2+10
D
2015-08-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.A - Grant$0.00+3,36233,708+11%+$0+1-600
D
2015-08-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.F - Tax$84.27-5,60533,708-14%-$472,333+1-600
D
2015-08-15
CAHCasey Donald M Jr.CEO, Medical SegmentA - Grant$0.00+9,553115,207+9%+$0+1-600
D
2015-08-15
CAHCasey Donald M Jr.CEO, Medical SegmentF - Tax$84.27-4,653115,207-4%-$392,108+1-600
D
2015-08-15
CAHLaws Stuart GSVP, Chief Accounting OfficerA - Grant$0.00+9899,984+11%+$0+1-600
D
2015-08-15
CAHLaws Stuart GSVP, Chief Accounting OfficerF - Tax$84.27-1,4499,984-13%-$122,107+1-600
D
2015-08-15
CAHMorford Craig SChief Legal, Compliance OfficeA - Grant$0.00+4,98481,820+6%+$0+1-600
D
2015-08-15
CAHMorford Craig SChief Legal, Compliance OfficeF - Tax$84.27-6,55381,820-7%-$552,221+1-600
D
2015-08-15
CAHKaufmann Michael CCFOA - Grant$0.00+9,790174,858+6%+$0+1-600
D
2015-08-15
CAHKaufmann Michael CCFOF - Tax$84.27-16,576174,858-9%-$1,396,860+1-600
D
2015-08-15
CAHGiacomin Jon LCEO, Pharmaceutical SegmentA - Grant$0.00+8,30727,144+44%+$0+1-600
D
2015-08-15
CAHGiacomin Jon LCEO, Pharmaceutical SegmentF - Tax$84.27-3,70727,144-12%-$312,389+1-600
D
2015-08-15
CAHBarrett George SCOB, CEOA - Grant$0.00+39,457406,134+11%+$0+1-600
D
2015-08-15
CAHBarrett George SCOB, CEOF - Tax$84.27-67,878406,134-14%-$5,720,079+1-600
D
2015-08-15
CAHWatkins Carole SCHROA - Grant$0.00+4,78634,245+16%+$0+1-600
D
2015-08-15
CAHWatkins Carole SCHROF - Tax$84.27-8,51234,245-20%-$717,306+1-600
D
2015-08-17
CAHWatkins Carole SCHROG - Gift$0.00-4,89034,245-12%-$0+1-600
D
2015-08-15
CAHFitzgerald MeghanEVP, Strategy, Health PolicyA - Grant$0.00+3,36217,020+25%+$0+1-600
D
2015-08-15
CAHFitzgerald MeghanEVP, Strategy, Health PolicyF - Tax$84.27-4,08517,020-19%-$344,243+1-600
D
2015-08-15
CAHMorrison PatriciaCIOA - Grant$0.00+4,56938,120+14%+$0+1-600
D
2015-08-15
CAHMorrison PatriciaCIOF - Tax$84.27-8,93938,120-19%-$753,290+1-600
2015-08-06
CAHAnderson David JDirP - Purchase$86.41+1,4003,428+69%+$120,9740-1-50
2015-08-04
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.A - Grant$0.00+6,96035,951+24%+$0-2-1-60
2014-11-19
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.G - Gift$0.00-7035,9510%-$0-2-1-60
2015-08-04
CAHMorford Craig SChief Legal, Compliance OfficeA - Grant$0.00+13,36483,389+19%+$0-2-1-60
2015-08-04
CAHCasey Donald M Jr.CEO, Medical SegmentA - Grant$0.00+23,387110,307+27%+$0-2-1-60
2015-08-04
CAHLaws Stuart GSVP, Chief Accounting OfficerA - Grant$0.00+2,78410,444+36%+$0-2-1-60
2015-08-04
CAHWatkins Carole SCHROA - Grant$0.00+11,13642,860+35%+$0-2-1-60
2015-05-18
CAHWatkins Carole SCHROG - Gift$0.00-16242,8600%-$0-2-1-60
2015-08-04
CAHKaufmann Michael CCFOA - Grant$0.00+23,387181,644+15%+$0-2-1-60
M
2014-11-07
CAHKaufmann Michael CCFOG - Gift$0.00-340181,6440%-$0-2-1-60
2015-08-04
CAHMorrison PatriciaCIOA - Grant$0.00+11,69342,490+38%+$0-2-1-60
2015-08-04
CAHBarrett George SCOB, CEOA - Grant$0.00+85,861434,555+25%+$0-2-1-60
2015-08-04
CAHGiacomin Jon LCEO, Pharmaceutical SegmentA - Grant$0.00+6,96022,544+45%+$0-2-1-60
2015-08-04
CAHFitzgerald MeghanEVP, Strategy, Health PolicyA - Grant$0.00+7,81817,743+79%+$0-2-1-60
D
2015-05-12
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.M - OptEx$40.77+39,42829,061-380%+$1,607,4940+1+4+3
D
2015-05-12
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$86.12-39,42829,061-58%-$3,395,5390+1+4+3
D
2015-05-11
CAHBarrett George SCOB, CEOM - OptEx$27.29+300,000348,694+616%+$8,187,0000+1+4+3
D
2015-05-11
CAHBarrett George SCOB, CEOS - Sale+OE$86.44-300,000348,694-46%-$25,932,0000+1+4+3
D
2015-05-08
CAHMorrison PatriciaCIOM - OptEx$41.60+36,04230,797-687%+$1,499,3470+1+4+3
D
2015-05-08
CAHMorrison PatriciaCIOS - Sale+OE$86.22-36,04230,797-54%-$3,107,5410+1+4+3
2015-04-16
CAHCasey Donald M Jr.CEO, Medical SegmentF - Tax$90.15-25186,9200%-$22,628+1+2-2-11
D
2015-03-03
CAHDarden CalvinDirM - OptEx$28.80+9,80122,771+76%+$282,2690-2+1-9
D
2015-03-03
CAHDarden CalvinDirS - Sale+OE$87.85-9,80122,771-30%-$861,0180-2+1-9
D
2015-03-03
CAHNotebaert Richard CDirM - OptEx$28.80+9,80135,778+38%+$282,2690-2+1-9
D
2015-03-03
CAHNotebaert Richard CDirS - Sale+OE$88.20-9,80135,778-22%-$864,4480-2+1-9
D
2015-03-04
CAHArnold Colleen F.DirM - OptEx$28.80+9,80121,597+83%+$282,2690-2+1-9
D
2015-03-04
CAHArnold Colleen F.DirS - Sale+OE$87.65-9,80121,597-31%-$859,0580-2+1-9
D
2015-02-20
CAHWatkins Carole SCHROM - OptEx$27.29+33,84731,868-1710%+$923,685+1+2+2-8
D
2015-02-20
CAHWatkins Carole SCHROS - Sale+OE$87.00-33,84731,868-52%-$2,944,689+1+2+2-8
DM
2014-11-24
CAHWatkins Carole SCHROG - Gift$0.00-8131,8700%-$0+1+1+4+2
D
2015-02-10
CAHWatkins Carole SCHROM - OptEx$27.29+50,77031,870-269%+$1,385,513+1+1+4+2
D
2015-02-10
CAHWatkins Carole SCHROS - Sale+OE$85.00-50,77031,870-61%-$4,315,450+1+1+4+2
D
2014-12-03
CAHBarrett George SCOB, CEOG - Gift$0.00-24,391348,694-7%-$0+1+1+4+2
D
2015-02-10
CAHBarrett George SCOB, CEOM - OptEx$27.29+300,000348,694+616%+$8,187,000+1+1+4+2
D
2015-02-10
CAHBarrett George SCOB, CEOS - Sale+OE$84.87-300,000348,694-46%-$25,461,000+1+1+4+2
D
2014-11-07
CAHBlake Mark REVP - Strategy, Corp. Dev.M - OptEx$43.92+22,48820,409-1082%+$987,656+1+2+2+10
D
2014-11-07
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale+OE$79.50-24,66820,409-55%-$1,961,106+1+2+2+10
2014-11-05
CAHKenny Gregory BDirA - Grant$0.00+2,28121,865+12%+$0-2+1+4+9
2014-11-05
CAHHall Patricia HemingwayDirA - Grant$0.00+2,0284,640+78%+$0-2+1+4+9
2014-11-05
CAHDowney BruceDirA - Grant$0.00+2,02831,067+7%+$0-2+1+4+9
D
2014-11-05
CAHDarden CalvinDirA - Grant$0.00+2,02822,771+10%+$0-2+1+4+9
D
2014-07-23
CAHFinn John FDirG - Gift$0.00-9843,9820%-$0-2+1+4+9
2014-11-05
CAHAnderson David JDirA - Grant$0.00+2,0282,028New+$0-2+1+4+9
2014-11-05
CAHKing David PDirA - Grant$0.00+2,02814,126+17%+$0-2+1+4+9
2014-11-05
CAHNotebaert Richard CDirA - Grant$0.00+2,02835,778+6%+$0-2+1+4+9
2014-11-05
CAHJones Clayton MDirA - Grant$0.00+2,0288,046+34%+$0-2+1+4+9
2014-11-05
CAHArnold Colleen F.DirA - Grant$0.00+2,02821,597+10%+$0-2+1+4+9
2014-11-05
CAHCox Carrie SmithDirA - Grant$0.00+2,02818,769+12%+$0-2+1+4+9
A
2014-09-18
CAHMorford Craig SChief Legal, Compliance OfficeG - Gift$0.00-1,77570,025-2%-$00-1-2+20
2014-09-15
CAHLaws Stuart GSVP, Chief Accounting OfficerA - Grant$0.00+6677,660+10%+$0-10-3+21
2014-09-15
CAHCasey Donald M Jr.CEO, Medical SegmentA - Grant$0.00+20,01187,171+30%+$0-10-3+21
2014-09-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentA - Grant$0.00+40,021158,597+34%+$0-10-3+21
D
2014-09-05
CAHWatkins Carole SCHROM - OptEx$41.10+40,79431,936-461%+$1,676,63300+1+18
D
2014-09-05
CAHWatkins Carole SCHROS - Sale+OE$75.00-40,79431,936-56%-$3,059,55000+1+18
D
2014-09-04
CAHKaufmann Michael CCEO, Pharmaceutical SegmentM - OptEx$41.10+50,216118,576+73%+$2,063,878+1+1+3+18
D
2014-09-04
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$74.95-50,216118,576-30%-$3,763,689+1+1+3+18
D
2014-08-27
CAHHenderson Jeffrey WilliamCFOM - OptEx$51.49+26,56767,190+65%+$1,367,935+1+3+4+23
D
2014-08-27
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$72.63-26,56767,190-28%-$1,929,561+1+3+4+23
2014-08-25
CAHKing David PDirS - Sale$73.55-3012,0980%-$2,207-1+1+4+21
D
2014-08-15
CAHMorford Craig SChief Legal, Compliance OfficeA - Grant$0.00+5,60070,025+9%+$00+1+4+20
D
2014-08-15
CAHMorford Craig SChief Legal, Compliance OfficeF - Tax$72.13-2,56270,025-4%-$184,7970+1+4+20
D
2014-08-14
CAHMorford Craig SChief Legal, Compliance OfficeG - Gift$0.00-1,77570,025-2%-$00+1+4+20
D
2014-08-15
CAHLaws Stuart GSVP, Chief Accounting OfficerA - Grant$0.00+1,1676,993+20%+$00+1+4+20
D
2014-08-15
CAHLaws Stuart GSVP, Chief Accounting OfficerF - Tax$72.13-1,2756,993-15%-$91,9660+1+4+20
D
2014-08-15
CAHBarrett George SCOB, CEOA - Grant$0.00+46,432373,085+14%+$00+1+4+20
D
2014-08-15
CAHBarrett George SCOB, CEOF - Tax$72.13-50,234373,085-12%-$3,623,3780+1+4+20
D
2014-08-15
CAHCasey Donald M Jr.CEO, Medical SegmentA - Grant$0.00+11,27067,160+20%+$00+1+4+20
D
2014-08-15
CAHCasey Donald M Jr.CEO, Medical SegmentF - Tax$72.13-2,89767,160-4%-$208,9610+1+4+20
D
2014-08-15
CAHBlake Mark REVP - Strategy, Corp. Dev.A - Grant$0.00+2,91722,589+15%+$00+1+4+20
D
2014-08-15
CAHBlake Mark REVP - Strategy, Corp. Dev.F - Tax$72.13-3,36022,589-13%-$242,3570+1+4+20
D
2014-08-18
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale+OE$72.15-4,78222,589-17%-$345,0210+1+4+20
D
2014-08-15
CAHHenderson Jeffrey WilliamCFOA - Grant$0.00+24,50067,190+57%+$00+1+4+20
D
2014-08-15
CAHHenderson Jeffrey WilliamCFOF - Tax$72.13-15,73567,190-19%-$1,134,9660+1+4+20
D
2014-08-18
CAHHenderson Jeffrey WilliamCFOM - OptEx$40.64+64,05867,190>999%+$2,603,6130+1+4+20
D
2014-08-18
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$72.06-78,63767,190-54%-$5,666,5820+1+4+20
D
2014-08-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.A - Grant$0.00+3,96729,061+16%+$00+1+4+20
D
2014-08-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.F - Tax$72.13-2,34329,061-7%-$169,0010+1+4+20
D
2014-08-15
CAHWatkins Carole SCHROA - Grant$0.00+5,13329,594+21%+$00+1+4+20
D
2014-08-15
CAHWatkins Carole SCHROF - Tax$72.13-6,30929,594-18%-$455,0680+1+4+20
D
2014-08-08
CAHWatkins Carole SCHROG - Gift$0.00-12229,5940%-$00+1+4+20
D
2014-08-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentA - Grant$0.00+11,760118,576+11%+$00+1+4+20
D
2014-08-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentF - Tax$72.13-13,743118,576-10%-$991,2830+1+4+20
D
2014-08-18
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$72.06-6,833118,576-5%-$492,3860+1+4+20
D
2014-08-11
CAHDowney BruceDirM - OptEx$25.32+10,65229,039+58%+$269,709+1+2+6+22
D
2014-08-08
CAHHenderson Jeffrey WilliamCFOM - OptEx$40.95+93,92573,004-449%+$3,846,0800+1+6+21
D
2014-08-08
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$69.72-118,09373,004-62%-$8,233,4440+1+6+21
D
2014-08-08
CAHMorford Craig SChief Legal, Compliance OfficeM - OptEx$41.00+38,38568,762+126%+$1,573,9130+1+6+21
D
2014-08-08
CAHMorford Craig SChief Legal, Compliance OfficeS - Sale+OE$70.03-43,35968,762-39%-$3,036,4310+1+6+21
2014-08-05
CAHWatkins Carole SCHROA - Grant$0.00+5,60830,892+22%+$00+2+7+21
2014-08-05
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.A - Grant$0.00+3,39827,437+14%+$00+2+7+21
2014-03-07
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.G - Gift$0.00-20027,437-1%-$00+2+7+21
2014-08-05
CAHHenderson Jeffrey WilliamCFOA - Grant$0.00+13,70897,172+16%+$00+2+7+21
2014-08-05
CAHLaws Stuart GSVP, Chief Accounting OfficerA - Grant$0.00+1,3257,101+23%+$00+2+7+21
2014-08-05
CAHBlake Mark REVP - Strategy, Corp. Dev.A - Grant$0.00+3,39827,814+14%+$00+2+7+21
2014-08-05
CAHCasey Donald M Jr.CEO, Medical SegmentA - Grant$0.00+14,78558,787+34%+$00+2+7+21
2014-08-05
CAHKaufmann Michael CCEO, Pharmaceutical SegmentA - Grant$0.00+11,423127,392+10%+$00+2+7+21
2014-08-05
CAHMorford Craig SChief Legal, Compliance OfficeA - Grant$0.00+6,16773,736+9%+$00+2+7+21
2014-02-05
CAHMorford Craig SChief Legal, Compliance OfficeG - Gift$0.00-81873,736-1%-$00+2+7+21
2014-08-05
CAHBarrett George SCOB, CEOA - Grant$0.00+42,785376,887+13%+$00+2+7+21
D
2014-07-24
CAHLaws Stuart GSVP, Chief Accounting OfficerM - OptEx$30.94+21,2665,776-137%+$657,97000+2+18
D
2014-07-24
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale+OE$72.50-21,2665,776-79%-$1,541,78500+2+18
D
2014-07-24
CAHBlake Mark REVP - Strategy, Corp. Dev.M - OptEx$40.96+23,11424,416>999%+$946,67500+2+18
D
2014-07-24
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale+OE$73.41-23,11424,416-49%-$1,696,79900+2+18
2014-07-14
CAHHenderson Jeffrey WilliamCFOS - Sale$70.65-23,63283,464-22%-$1,669,60100+1+17
2014-05-19
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale$66.50-4,70324,416-16%-$312,750+2+5+4+23
D
2014-05-12
CAHBarrett George SCOB, CEOM - OptEx$44.16+8,416334,102+3%+$371,6510+3+4+23
D
2014-05-12
CAHBarrett George SCOB, CEOS - Sale+OE$65.04-8,416334,102-2%-$547,3770+3+4+23
2014-05-13
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale$66.50-2,82229,119-9%-$187,6630+3+4+23
2014-05-07
CAHHenderson Jeffrey WilliamCFOS - Sale$63.83-27,031107,096-20%-$1,725,3890+2+11+26
2014-04-16
CAHCasey Donald M Jr.CEO, Medical SegmentF - Tax$67.21-25144,002-1%-$16,870+1-1-2+7
D
2014-02-10
CAHBarrett George SCOB, CEOM - OptEx$44.16+200,000334,102+149%+$8,832,0000+2+4+3
D
2014-02-10
CAHBarrett George SCOB, CEOS - Sale+OE$66.64-200,000334,102-37%-$13,328,0950+2+4+3
2014-02-07
CAHWatkins Carole SCHROS - Sale$67.01-28,26027,619-51%-$1,893,7030+2+4+3
DM
2014-02-10
CAHKaufmann Michael CCEO, Pharmaceutical SegmentM - OptEx$29.00+388,995115,969-142%+$11,281,2840+2+4+3
DM
2014-02-10
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$67.46-388,995115,969-77%-$26,242,4970+2+4+3
2014-02-11
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale$68.53-2,33031,941-7%-$159,6750+2+4+3
D
2014-02-04
CAHNotebaert Richard CDirM - OptEx$41.95+10,72733,750+47%+$449,946+1+6+11+9
D
2014-02-04
CAHNotebaert Richard CDirS - Sale+OE$65.68-10,72733,750-24%-$704,549+1+6+11+9
D
2014-02-05
CAHKenny Gregory BDirM - OptEx$36.72+18,17519,584>999%+$667,364+1+6+11+9
D
2014-02-05
CAHKenny Gregory BDirS - Sale+OE$65.39-18,17519,584-48%-$1,188,463+1+6+11+9
D
2013-12-20
CAHFinn John FDirG - Gift$0.00-2,24743,982-5%-$0+1+6+11+9
D
2014-02-04
CAHFinn John FDirM - OptEx$41.95+10,72743,982+32%+$449,946+1+6+11+9
D
2014-02-04
CAHFinn John FDirS - Sale+OE$65.68-10,72743,982-20%-$704,549+1+6+11+9
D
2014-02-05
CAHDarden CalvinDirM - OptEx$44.27+5,28220,743+34%+$233,834+1+6+11+9
D
2014-02-05
CAHDarden CalvinDirS - Sale+OE$65.43-5,28220,743-20%-$345,601+1+6+11+9
D
2014-02-04
CAHArnold Colleen F.DirM - OptEx$46.57+8,27019,569+73%+$385,117+1+6+11+9
D
2014-02-04
CAHArnold Colleen F.DirS - Sale+OE$65.46-8,27019,569-30%-$541,354+1+6+11+9
D
2014-02-04
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.M - OptEx$41.10+7,92624,239+49%+$325,759+1+6+11+9
D
2014-02-04
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$65.56-17,92624,239-43%-$1,175,229+1+6+11+9
DM
2014-02-03
CAHWatkins Carole SCHROG - Gift$0.00-35855,873-1%-$0+1+6+11+9
D
2014-02-04
CAHWatkins Carole SCHROM - OptEx$31.55+46,66655,873+507%+$1,472,255+1+6+11+9
D
2014-02-04
CAHWatkins Carole SCHROS - Sale+OE$65.71-46,66655,873-46%-$3,066,423+1+6+11+9
D
2014-02-03
CAHMorford Craig SChief Legal, Compliance OfficeM - OptEx$41.10+14,12868,387+26%+$580,661+1+6+11+9
D
2014-02-03
CAHMorford Craig SChief Legal, Compliance OfficeS - Sale+OE$66.95-27,29568,387-29%-$1,827,400+1+6+11+9
D
2014-02-03
CAHHenderson Jeffrey WilliamCFOM - OptEx$30.94+220,088134,127-256%+$6,809,523+1+6+11+9
D
2014-02-03
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$67.19-253,190134,127-65%-$17,011,836+1+6+11+9
D
2013-11-11
CAHBarrett George SCOB, CEOM - OptEx$42.40+200,000334,102+149%+$8,480,7520+3+5+5
D
2013-11-11
CAHBarrett George SCOB, CEOS - Sale+OE$62.71-200,000334,102-37%-$12,542,0000+3+5+5
2013-11-06
CAHNotebaert Richard CDirA - Grant$0.00+2,61233,750+8%+$0+2+6+6+8
2013-11-06
CAHKing David PDirA - Grant$0.00+2,61212,098+28%+$0+2+6+6+8
2013-11-06
CAHKenny Gregory BDirA - Grant$0.00+2,61219,584+15%+$0+2+6+6+8
2013-11-06
CAHJones Clayton MDirA - Grant$0.00+2,6126,018+77%+$0+2+6+6+8
2013-11-06
CAHHall Patricia HemingwayDirA - Grant$0.00+2,6122,612New+$0+2+6+6+8
2013-11-06
CAHFinn John FDirA - Grant$0.00+2,93946,229+7%+$0+2+6+6+8
2013-11-06
CAHDowney BruceDirA - Grant$0.00+2,61218,387+17%+$0+2+6+6+8
D
2013-11-06
CAHDarden CalvinDirA - Grant$0.00+2,61220,743+14%+$0+2+6+6+8
2013-11-06
CAHCox Carrie SmithDirA - Grant$0.00+2,61216,741+18%+$0+2+6+6+8
D
2013-11-06
CAHBritt GlennDirA - Grant$0.00+2,61218,314+17%+$0+2+6+6+8
2013-11-06
CAHArnold Colleen F.DirA - Grant$0.00+2,61219,569+15%+$0+2+6+6+8
D
2013-09-30
CAHLaws Stuart GSVP, Chief Accounting OfficerM - OptEx$29.08+23,8905,776-132%+$694,66100+5+34
D
2013-09-30
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale+OE$52.01-24,8795,776-81%-$1,293,95700+5+34
D
2013-09-11
CAHBlake Mark REVP - Strategy, Corp. Dev.M - OptEx$30.94+18,21434,271+113%+$563,5410+1+4+38
D
2013-09-11
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale+OE$51.53-14,58434,271-30%-$751,5140+1+4+38
2013-08-19
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale$51.27-4,92530,641-14%-$252,505-2-2+5+41
D
2013-08-15
CAHWatkins Carole SCHROA - Grant$0.00+6,47456,227+13%+$000+4+40
DM
2013-08-15
CAHWatkins Carole SCHROF - Tax$52.03-4,47556,227-7%-$232,84500+4+40
D
2013-08-15
CAHMorford Craig SChief Legal, Compliance OfficeA - Grant$0.00+7,76881,554+11%+$000+4+40
DM
2013-08-15
CAHMorford Craig SChief Legal, Compliance OfficeF - Tax$52.15-2,56081,554-3%-$133,49100+4+40
D
2013-08-14
CAHMorford Craig SChief Legal, Compliance OfficeG - Gift$0.00-3,88281,554-5%-$000+4+40
D
2013-08-15
CAHMorford Craig SChief Legal, Compliance OfficeS - Sale+OE$51.33-20,00081,554-20%-$1,026,60000+4+40
D
2013-08-15
CAHLaws Stuart GSVP, Chief Accounting OfficerA - Grant$0.00+1,6186,765+31%+$000+4+40
DM
2013-08-15
CAHLaws Stuart GSVP, Chief Accounting OfficerF - Tax$52.04-1,0546,765-13%-$54,84500+4+40
D
2013-08-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentA - Grant$0.00+13,595115,969+13%+$000+4+40
DM
2013-08-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentF - Tax$52.19-11,031115,969-9%-$575,74100+4+40
D
2013-08-15
CAHHenderson Jeffrey WilliamCFOA - Grant$0.00+15,861167,229+10%+$000+4+40
DM
2013-08-15
CAHHenderson Jeffrey WilliamCFOF - Tax$52.04-16,022167,229-9%-$833,77000+4+40
D
2013-08-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.A - Grant$0.00+4,45134,239+15%+$000+4+40
DM
2013-08-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.F - Tax$52.18-2,48934,239-7%-$129,88100+4+40
D
2013-08-16
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$51.50-10,00034,239-23%-$515,00000+4+40
D
2013-08-15
CAHCasey Donald M Jr.CEO, Medical SegmentA - Grant$0.00+14,95444,253+51%+$000+4+40
D
2013-08-15
CAHCasey Donald M Jr.CEO, Medical SegmentF - Tax$52.23-35744,253-1%-$18,64600+4+40
D
2013-08-15
CAHBlake Mark REVP - Strategy, Corp. Dev.A - Grant$0.00+4,04635,566+13%+$000+4+40
DM
2013-08-15
CAHBlake Mark REVP - Strategy, Corp. Dev.F - Tax$52.04-3,92135,566-10%-$204,03400+4+40
D
2013-08-15
CAHBarrett George SCOB, CEOA - Grant$0.00+55,674334,102+20%+$000+4+40
DM
2013-08-15
CAHBarrett George SCOB, CEOF - Tax$52.03-47,359334,102-12%-$2,464,02700+4+40
D
2013-08-13
CAHHenderson Jeffrey WilliamCFOM - OptEx$49.25+56,007167,390+50%+$2,758,3450-2+3+38
D
2013-08-13
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$51.99-54,590167,390-25%-$2,838,1340-2+3+38
2013-08-13
CAHBarrett George SCOB, CEOS - Sale$52.09-75,000325,787-19%-$3,906,7500-2+3+38
D
2013-08-08
CAHDarden CalvinDirM - OptEx$46.49+3,25418,131+22%+$151,27800-1+31
D
2013-08-08
CAHDarden CalvinDirS - Sale+OE$51.48-3,25418,131-15%-$167,51600-1+31
2013-08-06
CAHBarrett George SCOB, CEOA - Grant$0.00+33,990400,787+9%+$000-1+32
2013-08-06
CAHHenderson Jeffrey WilliamCFOA - Grant$0.00+10,889165,973+7%+$000-1+32
2013-08-06
CAHKaufmann Michael CCEO, Pharmaceutical SegmentA - Grant$0.00+9,075113,405+9%+$000-1+32
2013-08-06
CAHMorford Craig SChief Legal, Compliance OfficeA - Grant$0.00+4,898100,228+5%+$000-1+32
2013-08-06
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.A - Grant$0.00+2,70042,277+7%+$000-1+32
2013-08-06
CAHLaws Stuart GSVP, Chief Accounting OfficerA - Grant$0.00+1,0516,201+20%+$000-1+32
2013-08-06
CAHBlake Mark REVP - Strategy, Corp. Dev.A - Grant$0.00+2,70035,441+8%+$000-1+32
2013-08-06
CAHWatkins Carole SCHROA - Grant$0.00+4,45454,229+9%+$000-1+32
D
2013-08-05
CAHBlake Mark REVP - Strategy, Corp. Dev.M - OptEx$30.94+36,42732,741-988%+$1,127,051+1+2-1+31
D
2013-08-05
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale+OE$51.53-29,16632,741-47%-$1,502,924+1+2-1+31
D
2013-07-26
CAHHenderson Jeffrey WilliamCFOM - OptEx$27.29+100,000155,084+182%+$2,729,000-1+2-1+35
D
2013-07-26
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$50.99-76,781155,084-33%-$3,915,063-1+2-1+35
D
2013-07-18
CAHHenderson Jeffrey WilliamCFOM - OptEx$48.58+58,379131,865+79%+$2,836,0520+1+1+35
D
2013-07-18
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$49.99-57,623131,865-30%-$2,880,5740+1+1+35
D
2013-07-15
CAHHenderson Jeffrey WilliamCFOM - OptEx$48.58+14,853131,109+13%+$721,559+1+1+4+38
D
2013-07-15
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$49.99-14,660131,109-10%-$732,853+1+1+4+38
D
2013-07-11
CAHHenderson Jeffrey WilliamCFOM - OptEx$27.29+106,843130,916+444%+$2,915,745-1+2+5+38
D
2013-07-11
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$48.99-83,211130,916-39%-$4,076,507-1+2+5+38
D
2013-06-19
CAHFinn John FDirM - OptEx$44.50+8,25543,290+24%+$367,3720+2+8+44
D
2013-06-19
CAHFinn John FDirS - Sale+OE$48.51-11,07043,290-20%-$537,0370+2+8+44
DM
2013-05-24
CAHSpaulding Jean GDirM - OptEx$45.12+8,53617,182+99%+$385,1130-2+1+39
DM
2013-05-24
CAHSpaulding Jean GDirS - Sale+OE$47.35-8,35017,182-33%-$395,4140-2+1+39
D
2013-05-22
CAHNotebaert Richard CDirM - OptEx$46.49+3,25431,138+12%+$151,278-10-1+38
D
2013-05-22
CAHNotebaert Richard CDirS - Sale+OE$48.10-3,19731,138-9%-$153,776-10-1+38
2013-05-22
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale$47.52-36104,3300%-$1,711-10-1+38
D
2013-05-20
CAHWatkins Carole SCHROM - OptEx$22.90+6,49449,763+15%+$148,713-1-2-2+37
D
2013-05-20
CAHWatkins Carole SCHROS - Sale+OE$48.00-4,61249,763-8%-$221,376-1-2-2+37
D
2013-05-20
CAHMorford Craig SChief Legal, Compliance OfficeM - OptEx$27.29+60,44195,330+173%+$1,649,435-1-2-2+37
D
2013-05-20
CAHMorford Craig SChief Legal, Compliance OfficeS - Sale+OE$48.00-45,99495,330-33%-$2,207,712-1-2-2+37
2013-05-20
CAHSpaulding Jean GDirS - Sale$47.90-1,66616,996-9%-$79,801-1-2-2+37
2013-05-14
CAHCox Carrie SmithDirP - Purchase$46.25+43514,129+3%+$20,1190+2+2+36
D
2013-05-06
CAHWatkins Carole SCHROG - Gift$0.00-1,08747,882-2%-$0-1+1+1+32
D
2013-05-07
CAHWatkins Carole SCHROM - OptEx$22.90+5,28447,882+12%+$121,004-1+1+1+32
D
2013-05-07
CAHWatkins Carole SCHROS - Sale+OE$45.95-25,59247,882-35%-$1,175,952-1+1+1+32
D
2013-05-07
CAHBlake Mark REVP - Strategy, Corp. Dev.M - OptEx$27.91+38,35025,480-298%+$1,070,349-1+1+1+32
D
2013-05-07
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale+OE$46.00-30,82525,480-55%-$1,417,950-1+1+1+32
2013-05-06
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale$46.14-14,25339,577-26%-$657,633-1+1+1+32
D
2013-05-08
CAHMorford Craig SChief Legal, Compliance OfficeG - Gift$0.00-1,50780,883-2%-$0-1+1+1+32
DM
2013-05-07
CAHMorford Craig SChief Legal, Compliance OfficeM - OptEx$27.29+60,44280,883+296%+$1,649,462-1+1+1+32
DM
2013-05-07
CAHMorford Craig SChief Legal, Compliance OfficeS - Sale+OE$46.12-48,14080,883-37%-$2,220,458-1+1+1+32
D
2013-05-07
CAHHenderson Jeffrey WilliamCFOG - Gift$0.00-239107,2840%-$0-1+1+1+32
D
2013-05-06
CAHHenderson Jeffrey WilliamCFOM - OptEx$33.93+205,531107,284-209%+$6,974,681-1+1+1+32
D
2013-05-06
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$46.18-207,918107,284-66%-$9,601,653-1+1+1+32
D
2013-05-06
CAHNotebaert Richard CDirM - OptEx$43.21+5,00131,081+19%+$216,093-1+1+1+32
D
2013-05-06
CAHNotebaert Richard CDirS - Sale+OE$46.25-5,00131,081-14%-$231,296-1+1+1+32
D
2013-05-06
CAHSpaulding Jean GDirM - OptEx$41.38+10,44718,662+127%+$432,248-1+1+1+32
D
2013-05-06
CAHSpaulding Jean GDirS - Sale+OE$46.19-10,44718,662-36%-$482,547-1+1+1+32
2013-04-16
CAHCasey Donald M Jr.CEO, Medical SegmentF - Tax$43.01-24929,656-1%-$10,7090+4+10+30
D
2013-01-23
CAHMorford Craig SChief Legal, Compliance OfficeM - OptEx$27.29+60,44170,088+627%+$1,649,4350-2+1+12
D
2013-01-23
CAHMorford Craig SChief Legal, Compliance OfficeS - Sale+OE$45.00-47,27470,088-40%-$2,127,3300-2+1+12
D
2012-12-03
CAHKaufmann Michael CCEO, Pharmaceutical SegmentG - Gift$0.00-300104,3620%-$00-2+1+12
D
2013-01-23
CAHKaufmann Michael CCEO, Pharmaceutical SegmentM - OptEx$27.29+55,158104,362+112%+$1,505,2620-2+1+12
D
2013-01-23
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$44.95-58,362104,362-36%-$2,623,3720-2+1+12
D
2013-01-23
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.M - OptEx$27.29+49,96553,830>999%+$1,363,5450-2+1+12
D
2013-01-23
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$45.00-39,08053,830-42%-$1,758,6000-2+1+12
D
2013-01-14
CAHWatkins Carole SCHROF - Tax$43.06-50969,265-1%-$21,918+1+2+7+16
D
2013-01-14
CAHWatkins Carole SCHROM - OptEx$22.90+64369,265+1%+$14,725+1+2+7+16
D
2013-01-10
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.M - OptEx$27.29+49,96542,945-712%+$1,363,545+1+3+5+15
D
2013-01-10
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$43.00-39,86742,945-48%-$1,714,281+1+3+5+15
2013-01-10
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale$42.92-1,47117,955-8%-$63,135+1+3+5+15
2012-12-14
CAHBlake Mark REVP - Strategy, Corp. Dev.S - Sale$42.25-2,33019,426-11%-$98,443+1-1+5+16
D
2012-11-02
CAHSpaulding Jean GDirA - Grant$0.00+3,40618,662+22%+$0+1-20+15
D
2012-11-02
CAHSpaulding Jean GDirA - Grant$0.00+3,40618,662+22%+$0+1-20+15
2012-11-02
CAHNotebaert Richard CDirA - Grant$0.00+3,40631,081+12%+$0+1-20+15
2012-11-02
CAHKing David PDirA - Grant$0.00+3,4069,486+56%+$0+1-20+15
2012-11-02
CAHKenny Gregory BDirA - Grant$0.00+3,40616,972+25%+$0+1-20+15
2012-11-02
CAHJones Clayton MDirA - Grant$0.00+3,4063,406New+$0+1-20+15
D
2012-11-02
CAHFinn John FDirA - Grant$0.00+3,89346,105+9%+$0+1-20+15
2012-11-02
CAHDowney BruceDirA - Grant$0.00+3,40615,775+28%+$0+1-20+15
D
2012-11-02
CAHDarden CalvinDirA - Grant$0.00+3,40618,131+23%+$0+1-20+15
2012-11-02
CAHCox Carrie SmithDirA - Grant$0.00+3,40613,694+33%+$0+1-20+15
D
2012-11-02
CAHBritt GlennDirA - Grant$0.00+3,40615,702+28%+$0+1-20+15
2012-11-02
CAHArnold Colleen F.DirA - Grant$0.00+3,40616,957+25%+$0+1-20+15
2012-11-01
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale$41.22-2,5645,150-33%-$105,688-2-3-2+15
2012-10-15
CAHBlake Mark REVP - Strategy, Corp. Dev.F - Tax$40.89-1,09521,756-5%-$44,775-1-3-6+5
D
2012-10-04
CAHHenderson Jeffrey WilliamCFOM - OptEx$27.29+50,000109,910+83%+$1,364,500+1+2-2+7
D
2012-10-04
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$40.00-46,226109,910-30%-$1,849,040+1+2-2+7
2012-09-15
CAHWatkins Carole SCHROF - Tax$38.37-1,29169,105-2%-$49,536+1+2+11+11
2012-09-15
CAHMorford Craig SChief Legal, Compliance OfficeF - Tax$38.37-21056,9210%-$8,058+1+2+11+11
2012-09-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentF - Tax$38.37-382107,8660%-$14,657+1+2+11+11
2012-09-15
CAHLaws Stuart GSVP, Chief Accounting OfficerF - Tax$38.37-3067,714-4%-$11,741+1+2+11+11
2012-09-15
CAHHenderson Jeffrey WilliamCFOF - Tax$38.37-4,143106,136-4%-$158,967+1+2+11+11
2012-09-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.F - Tax$38.37-76332,847-2%-$29,276+1+2+11+11
2012-09-15
CAHBarrett George SCOB, CEOF - Tax$38.37-21,881366,797-6%-$839,574+1+2+11+11
D
2012-09-10
CAHHenderson Jeffrey WilliamCFOM - OptEx$27.29+50,000110,279+83%+$1,364,500-1+1+8+24
DM
2012-09-07
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$38.32-79,410110,279-42%-$3,043,171-1+1+8+24
D
2012-08-15
CAHLaws Stuart GSVP, Chief Accounting OfficerA - Grant$0.00+2,0938,020+35%+$00-1-4+17
DM
2012-08-15
CAHLaws Stuart GSVP, Chief Accounting OfficerF - Tax$39.79-4668,020-5%-$18,5440-1-4+17
D
2012-08-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.A - Grant$0.00+5,75733,610+21%+$00-1-4+17
DM
2012-08-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.F - Tax$39.79-18733,610-1%-$7,4410-1-4+17
D
2012-08-15
CAHWatkins Carole SCHROA - Grant$0.00+8,79270,396+14%+$00-1-4+17
DM
2012-08-15
CAHWatkins Carole SCHROF - Tax$39.21-1,96970,396-3%-$77,2140-1-4+17
D
2012-08-15
CAHMorford Craig SChief Legal, Compliance OfficeA - Grant$0.00+10,55057,131+23%+$00-1-4+17
DM
2012-08-15
CAHMorford Craig SChief Legal, Compliance OfficeF - Tax$39.79-32457,131-1%-$12,8930-1-4+17
D
2012-08-15
CAHCasey Donald M Jr.CEO, Medical SegmentA - Grant$0.00+17,58429,905+143%+$00-1-4+17
D
2012-08-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentA - Grant$0.00+20,221108,248+23%+$00-1-4+17
DM
2012-08-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentF - Tax$39.78-2,351108,248-2%-$93,5130-1-4+17
D
2012-08-15
CAHHenderson Jeffrey WilliamCFOA - Grant$0.00+21,540139,689+18%+$00-1-4+17
DM
2012-08-15
CAHHenderson Jeffrey WilliamCFOF - Tax$39.79-5,014139,689-3%-$199,5180-1-4+17
D
2012-08-15
CAHBarrett George SCOB, CEOA - Grant$0.00+69,455388,678+22%+$00-1-4+17
DM
2012-08-15
CAHBarrett George SCOB, CEOF - Tax$39.79-17,864388,678-4%-$710,8930-1-4+17
D
2012-08-15
CAHBlake Mark REVP - Strategy, Corp. Dev.A - Grant$0.00+5,23322,851+30%+$00-1-4+17
DM
2012-08-15
CAHBlake Mark REVP - Strategy, Corp. Dev.F - Tax$39.79-1,22022,851-5%-$48,5470-1-4+17
D
2012-05-17
CAHSpaulding Jean GDirM - OptEx$28.80+9,80115,406+175%+$282,2690+1+2-4
D
2012-05-17
CAHSpaulding Jean GDirS - Sale+OE$42.06-8,13515,406-35%-$342,1580+1+2-4
D
2012-03-01
CAHFinn John FDirG - Gift$0.00-51,55842,212-552%-$0-1-3-6-4
D
2012-04-16
CAHCasey Donald M Jr.CEO, Medical SegmentA - Grant$0.00+12,32112,321New+$0-1-1+1+1
D
2012-02-27
CAHLynch Michael ACEO, Medical SegmentM - OptEx$27.29+39,40089,204+79%+$1,075,226-1-2+2-4
D
2012-02-27
CAHLynch Michael ACEO, Medical SegmentS - Sale+OE$42.00-31,37389,204-26%-$1,317,666-1-2+2-4
D
2012-02-24
CAHLynch Michael ACEO, Medical SegmentM - OptEx$32.26+32,17381,177+66%+$1,037,965-1-2+3-5
D
2012-02-24
CAHLynch Michael ACEO, Medical SegmentS - Sale+OE$41.59-40,17381,177-33%-$1,670,795-1-2+3-5
D
2011-11-02
CAHSpaulding Jean GDirA - Grant$0.00+3,19513,740+30%+$0-1-2-7-2
2011-11-02
CAHRaisbeck David WDirA - Grant$0.00+3,19517,075+23%+$0-1-2-7-2
2011-11-02
CAHNotebaert Richard CDirA - Grant$0.00+3,19527,675+13%+$0-1-2-7-2
2011-11-02
CAHKenny Gregory BDirA - Grant$0.00+3,19513,566+31%+$0-1-2-7-2
2011-11-02
CAHKing David PDirA - Grant$0.00+3,1956,080+111%+$0-1-2-7-2
D
2011-11-02
CAHFinn John FDirA - Grant$0.00+3,65142,212+9%+$0-1-2-7-2
2011-11-02
CAHDowney BruceDirA - Grant$0.00+3,19512,369+35%+$0-1-2-7-2
D
2011-11-02
CAHDarden CalvinDirA - Grant$0.00+3,19514,725+28%+$0-1-2-7-2
2011-11-02
CAHCox Carrie SmithDirA - Grant$0.00+3,19510,288+45%+$0-1-2-7-2
D
2011-11-02
CAHBritt GlennDirA - Grant$0.00+3,19512,296+35%+$0-1-2-7-2
2010-11-02
CAHArnold Colleen F.DirA - Grant$0.00+3,19513,551+31%+$0-1-2-7-2
DM
2011-10-26
CAHKaufmann Michael CCEO, Pharmaceutical SegmentM - OptEx$27.29+55,15890,678+155%+$1,505,262-3-4-10-6
DM
2011-10-26
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$44.95-43,16490,678-32%-$1,940,222-3-4-10-6
2011-10-19
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale$42.40-1,3416,393-17%-$56,858+4+6-1-1
2011-10-15
CAHBlake Mark REVP - Strategy, Corp. Dev.F - Tax$42.09-1,09518,838-5%-$46,089+2+7+7+1
2011-09-15
CAHWatkins Carole SCHROF - Tax$41.58-1,59363,526-2%-$66,2370-3-4-3
2011-09-15
CAHLynch Michael ACEO, Medical SegmentF - Tax$41.58-3,01789,177-3%-$125,4470-3-4-3
2011-09-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentF - Tax$41.58-44478,684-1%-$18,4620-3-4-3
2011-09-15
CAHMorford Craig SChief Legal, Compliance OfficeF - Tax$41.58-21046,9050%-$8,7320-3-4-3
2011-09-15
CAHHenderson Jeffrey WilliamCFOF - Tax$41.58-4,143123,643-3%-$172,2660-3-4-3
2011-09-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.F - Tax$41.58-76328,290-3%-$31,7260-3-4-3
2011-09-15
CAHBarrett George SCOB, CEOF - Tax$41.58-21,880337,087-6%-$909,7700-3-4-3
2011-09-15
CAHLaws Stuart GSVP, Chief Accounting OfficerF - Tax$41.58-3057,734-4%-$12,682+4+1+2+2
2011-09-14
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale$41.14-1,1917,734-13%-$48,998+4+1+2+2
2011-09-01
CAHKing David PDirA - Grant$0.00+2,8452,885>999%+$00-4-3+1
D
2011-08-15
CAHLaws Stuart GSVP, Chief Accounting OfficerA - Grant$0.00+1,8399,230+25%+$0-4-2+3+1
DM
2011-08-15
CAHLaws Stuart GSVP, Chief Accounting OfficerF - Tax$41.20-5969,230-6%-$24,555-4-2+3+1
D
2011-08-17
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale+OE$41.73-1,1009,230-11%-$45,903-4-2+3+1
D
2011-08-15
CAHLynch Michael ACEO, Medical SegmentA - Grant$0.00+18,79392,194+26%+$0-4-2+3+1
DM
2011-08-15
CAHLynch Michael ACEO, Medical SegmentF - Tax$41.39-3,29692,194-3%-$136,422-4-2+3+1
D
2011-08-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentA - Grant$0.00+18,79379,128+31%+$0-4-2+3+1
DM
2011-08-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentF - Tax$41.03-1,85779,128-2%-$76,191-4-2+3+1
D
2011-08-15
CAHWatkins Carole SCHROA - Grant$0.00+7,78865,119+14%+$0-4-2+3+1
DM
2011-08-15
CAHWatkins Carole SCHROF - Tax$41.28-2,03865,119-3%-$84,125-4-2+3+1
D
2011-08-15
CAHBarrett George SCOB, CEOA - Grant$0.00+64,103358,967+22%+$0-4-2+3+1
DM
2011-08-15
CAHBarrett George SCOB, CEOF - Tax$41.44-14,708358,967-4%-$609,431-4-2+3+1
D
2011-08-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.A - Grant$0.00+5,19229,053+22%+$0-4-2+3+1
DM
2011-08-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.F - Tax$40.99-65229,053-2%-$26,722-4-2+3+1
D
2011-08-15
CAHMorford Craig SChief Legal, Compliance OfficeA - Grant$0.00+8,56447,115+22%+$0-4-2+3+1
DM
2011-08-15
CAHMorford Craig SChief Legal, Compliance OfficeF - Tax$41.28-32747,115-1%-$13,500-4-2+3+1
D
2011-08-15
CAHBlake Mark REVP - Strategy, Corp. Dev.A - Grant$0.00+4,95619,933+33%+$0-4-2+3+1
D
2011-08-16
CAHBlake Mark REVP - Strategy, Corp. Dev.F - Tax$41.60-69119,933-3%-$28,746-4-2+3+1
D
2011-08-15
CAHHenderson Jeffrey WilliamCFOA - Grant$0.00+20,942127,786+20%+$0-4-2+3+1
DM
2011-08-15
CAHHenderson Jeffrey WilliamCFOF - Tax$41.29-5,209127,786-4%-$215,105-4-2+3+1
2011-07-13
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale$46.68-1,1009,087-11%-$51,34800-11-8
D
2011-07-07
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.M - OptEx$31.40+13,61724,513+125%+$427,620-1-1-14-12
D
2011-07-07
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$47.00-11,12124,513-31%-$522,687-1-1-14-12
2011-07-06
CAHFinn John FDirS - Sale$46.50-2,86438,561-7%-$133,176-1-1-14-12
D
2011-07-01
CAHWatkins Carole SCHROM - OptEx$22.90+9,27659,358+19%+$212,420+10-9-10
D
2011-07-01
CAHWatkins Carole SCHROS - Sale+OE$46.00-6,69859,358-10%-$308,108+10-9-10
D
2011-07-01
CAHKaufmann Michael CCEO, Pharmaceutical SegmentM - OptEx$32.33+10,14362,192+19%+$327,923+10-9-10
D
2011-07-01
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$45.95-10,14362,192-14%-$466,071+10-9-10
2011-06-15
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale$43.79-1,10010,187-10%-$48,1690+2+7-5
D
2011-05-19
CAHHenderson Jeffrey WilliamCFOM - OptEx$39.68+47,304112,053+73%+$1,877,023-10-2-4
D
2011-05-19
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$45.25-57,854112,053-34%-$2,617,894-10-2-4
2011-05-15
CAHMorford Craig SChief Legal, Compliance OfficeF - Tax$44.45-14638,8780%-$6,4900-1-3+1
2011-05-11
CAHLaws Stuart GSVP, Chief Accounting OfficerS - Sale$44.96-1,02511,287-8%-$46,084-1+1-3-4
D
2011-05-05
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.M - OptEx$22.90+3,43722,017+18%+$78,707+20-10
D
2011-05-05
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$45.00-6,95422,017-24%-$312,930+20-10
D
2011-05-05
CAHKaufmann Michael CCEO, Pharmaceutical SegmentM - OptEx$32.33+10,14362,192+19%+$327,923+20-10
D
2011-05-05
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$44.95-10,14362,192-14%-$455,928+20-10
D
2011-04-27
CAHKaufmann Michael CCEO, Pharmaceutical SegmentM - OptEx$32.33+10,14362,192+19%+$327,923-1+1+3-1
D
2011-04-27
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$43.95-10,14362,192-14%-$445,785-1+1+3-1
D
2011-04-26
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.M - OptEx$22.90+3,05325,534+14%+$69,914-1+1+3-1
D
2011-04-26
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.S - Sale+OE$43.00-2,26725,534-8%-$97,481-1+1+3-1
D
2011-04-26
CAHHenderson Jeffrey WilliamCFOM - OptEx$39.68+59,035122,603+93%+$2,342,509-1+1+3-1
D
2011-04-26
CAHHenderson Jeffrey WilliamCFOS - Sale+OE$43.00-59,035122,603-33%-$2,538,505-1+1+3-1
2011-04-21
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale$42.95-8,56062,192-12%-$367,6520+2+30
D
2011-03-18
CAHKaufmann Michael CCEO, Pharmaceutical SegmentM - OptEx$22.90+17770,7520%+$4,0530+1+3+7
D
2011-03-18
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$40.95-17770,7520%-$7,2480+1+3+7
2011-02-15
CAHBarrett George SCOB, CEOF - Tax$41.97-11,944309,572-4%-$501,2900-3-3+1
D
2011-02-07
CAHKaufmann Michael CCEO, Pharmaceutical SegmentM - OptEx$25.90+80,64870,752-815%+$2,088,983-1+1-1-4
D
2011-02-07
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale+OE$41.71-87,54470,752-55%-$3,651,460-1+1-1-4
D
2011-01-21
CAHFinn John FDirG - Gift$0.00+5,62641,425-12%+$0+1-1+2+2
2010-12-03
CAHFinn John FDirG - Gift$0.00-2,00041,425-5%-$0-20+6+19
2010-12-03
CAHKaufmann Michael CCEO, Pharmaceutical SegmentS - Sale$37.29-63377,648-1%-$23,605-20+6+19
2010-12-03
CAHHenderson Jeffrey WilliamCFOG - Gift$0.00-700122,603-1%-$0-20+6+19
M
2010-12-02
CAHWatkins Carole SCHROG - Gift$0.00-55056,769-1%-$0-20+6+19
D
2010-11-03
CAHSpaulding Jean GDirA - Grant$0.00+3,39610,545+48%+$0-1-1+4+26
2010-11-03
CAHRaisbeck David WDirA - Grant$0.00+3,39613,880+32%+$0-1-1+4+26
2010-11-03
CAHMongan James J MdDirA - Grant$0.00+3,3967,150+90%+$0-1-1+4+26
D
2010-11-03
CAHDarden CalvinDirA - Grant$0.00+3,39611,530+42%+$0-1-1+4+26
2010-11-03
CAHNotebaert Richard CDirA - Grant$0.00+3,39624,480+16%+$0-1-1+4+26
2010-11-03
CAHDowney BruceDirA - Grant$0.00+3,3969,174+59%+$0-1-1+4+26
2010-11-03
CAHArnold Colleen F.DirA - Grant$0.00+3,39610,356+49%+$0-1-1+4+26
D
2010-11-03
CAHFinn John FDirA - Grant$0.00+3,96243,425+10%+$0-1-1+4+26
2010-11-03
CAHKenny Gregory BDirA - Grant$0.00+3,39610,371+49%+$0-1-1+4+26
D
2010-11-03
CAHBritt GlennDirA - Grant$0.00+3,3969,101+60%+$0-1-1+4+26
2010-11-03
CAHCox Carrie SmithDirA - Grant$0.00+3,3967,093+92%+$0-1-1+4+26
2010-10-15
CAHBlake Mark REVP - Strategy, Corp. Dev.F - Tax$33.31-1,09415,668-7%-$36,441-3-3+3+25
2010-09-15
CAHWatkins Carole SCHROF - Tax$31.79-1,69557,306-3%-$53,88400+3+25
2010-09-15
CAHMorford Craig SChief Legal, Compliance OfficeF - Tax$31.79-24439,024-1%-$7,75700+3+25
2010-09-15
CAHLynch Michael ACEO, Medical SegmentF - Tax$31.79-3,34076,697-4%-$106,17900+3+25
2010-09-15
CAHLaws Stuart GSVP, Chief Accounting OfficerF - Tax$31.79-30512,312-2%-$9,69600+3+25
2010-09-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentF - Tax$31.79-44478,281-1%-$14,11500+3+25
2010-09-15
CAHHenderson Jeffrey WilliamCFOF - Tax$31.79-4,143123,303-3%-$131,70600+3+25
2010-09-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.F - Tax$31.79-76324,748-3%-$24,25600+3+25
2010-09-15
CAHBarrett George SCOB, CEOF - Tax$31.79-21,880321,516-6%-$695,56500+3+25
2010-09-03
CAHBarrett George SCOB, CEOA - Grant$31.29+13,423343,396+4%+$420,006+1+2+4+37
2010-09-03
CAHBarrett George SCOB, CEOF - Tax$31.29-5,631343,396-2%-$176,194+1+2+4+37
2010-08-16
CAHWatkins Carole SCHROA - Grant$0.00+10,69059,001+22%+$00-4+4+35
2010-08-15
CAHWatkins Carole SCHROF - Tax$31.36-1,84159,001-3%-$57,7340-4+4+35
D
2010-08-16
CAHBlake Mark REVP - Strategy, Corp. Dev.A - Grant$0.00+6,48816,762+63%+$00-4+4+35
D
2010-08-16
CAHHenderson Jeffrey WilliamCFOA - Grant$0.00+26,131127,446+26%+$00-4+4+35
D
2010-08-15
CAHHenderson Jeffrey WilliamCFOF - Tax$31.36-4,711127,446-4%-$147,7370-4+4+35
D
2010-08-16
CAHKaufmann Michael CCEO, Pharmaceutical SegmentA - Grant$0.00+21,65278,725+38%+$00-4+4+35
D
2010-08-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentF - Tax$31.36-1,83278,725-2%-$57,4520-4+4+35
D
2010-08-16
CAHLynch Michael ACEO, Medical SegmentA - Grant$0.00+22,39880,037+39%+$00-4+4+35
D
2010-08-15
CAHLynch Michael ACEO, Medical SegmentF - Tax$31.36-1,60180,037-2%-$50,2070-4+4+35
D
2010-08-16
CAHLaws Stuart GSVP, Chief Accounting OfficerA - Grant$0.00+2,52512,617+25%+$00-4+4+35
D
2010-08-15
CAHLaws Stuart GSVP, Chief Accounting OfficerF - Tax$31.36-44912,617-3%-$14,0810-4+4+35
2010-08-16
CAHMorford Craig SChief Legal, Compliance OfficeA - Grant$0.00+11,45439,268+41%+$00-4+4+35
2010-08-15
CAHMorford Craig SChief Legal, Compliance OfficeF - Tax$31.36-14239,2680%-$4,4530-4+4+35
D
2010-08-16
CAHBarrett George SCOB, CEOA - Grant$0.00+81,448335,604+32%+$00-4+4+35
D
2010-08-15
CAHBarrett George SCOB, CEOF - Tax$31.36-3,317335,604-1%-$104,0210-4+4+35
2010-08-16
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.A - Grant$0.00+6,31225,511+33%+$00-4+4+35
2010-08-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.F - Tax$31.36-72625,511-3%-$22,7670-4+4+35
2010-07-16
CAHLynch Michael ACEO, Medical SegmentF - Tax$35.88-49159,240-1%-$17,617-1-6-11+19
2010-05-15
CAHMorford Craig SChief Legal, Compliance OfficeF - Tax$33.82-14627,956-1%-$4,938-1-4+5+3
2010-03-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentF - Tax$34.91-26758,9050%-$9,3210+3+2-9
2010-02-15
CAHBarrett George SCOB, CEOF - Tax$33.38-11,329257,473-4%-$378,162+1-2+6-7
2010-02-01
CAHWatkins Carole SCHROF - Tax$33.07-5,48650,130-10%-$181,422-2-5+3-3
2010-02-01
CAHMorford Craig SChief Legal, Compliance OfficeF - Tax$33.07-2,66328,102-9%-$88,065-2-5+3-3
2010-02-01
CAHHenderson Jeffrey WilliamCFOF - Tax$33.07-9,682106,026-8%-$320,184-2-5+3-3
2010-02-01
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.F - Tax$33.07-2,70419,925-12%-$89,421-2-5+3-3
2010-02-01
CAHKaufmann Michael CCEO, Pharmaceutical SegmentF - Tax$33.07-6,11359,172-9%-$202,157-2-5+3-3
2010-02-01
CAHLaws Stuart GSVP, Chief Accounting OfficerF - Tax$33.07-2,16310,541-17%-$71,530-2-5+3-3
2010-02-01
CAHLynch Michael ACEO, Medical SegmentF - Tax$33.07-5,40159,731-8%-$178,611-2-5+3-3
2010-01-22
CAHMongan James J MdDirA - Grant$31.97+3,7543,754New+$120,015-3+6+4+4
2009-12-03
CAHFinn John FDirG - Gift$0.00-2,28039,463-5%-$0-2-1+1+9
2010-01-01
CAHWatkins Carole SCHROF - Tax$32.24-1,31355,603-2%-$42,331-2-1+1+9
2009-12-01
CAHCox Carrie SmithDirA - Grant$32.46+3,6973,697New+$120,005-2-3-1+5
D
2009-11-04
CAHSpaulding Jean GDirA - Grant$29.13+4,1197,149+136%+$119,9860+5+10+19
2009-11-04
CAHRaisbeck David WDirA - Grant$29.13+4,11910,484+65%+$119,9860+5+10+19
D
2009-11-04
CAHNotebaert Richard CDirA - Grant$29.13+4,11921,084+24%+$119,9860+5+10+19
D
2009-11-04
CAHKenny Gregory BDirA - Grant$29.13+4,1196,975+144%+$119,9860+5+10+19
2009-11-04
CAHFinn John FDirA - Grant$29.13+4,80642,543+13%+$139,9990+5+10+19
2009-11-04
CAHDowney BruceDirA - Grant$29.13+4,1195,778+248%+$119,9860+5+10+19
D
2009-11-04
CAHDarden CalvinDirA - Grant$29.13+4,1198,134+103%+$119,9860+5+10+19
2009-11-04
CAHBritt GlennDirA - Grant$29.13+4,1195,705+260%+$119,9860+5+10+19
D
2009-11-04
CAHArnold Colleen F.DirA - Grant$29.13+4,1196,960+145%+$119,9860+5+10+19
D
2009-10-15
CAHBlake Mark REVP, Strategy, Corp. Dev.A - Grant$27.91+10,27410,274New+$286,747-1-1+9+24
D
2009-10-01
CAHBritt GlennDirA - Grant$26.49+1,5861,586New+$42,013-1+3+7+39
D
2009-09-15
CAHLynch Michael ACEO, Medical SegmentA - Grant$27.29+25,39465,132+64%+$693,0020-3+4+30
D
2009-09-15
CAHWatkins Carole SCHROA - Grant$27.29+12,12056,902+27%+$330,7550-3+4+30
D
2009-09-15
CAHMorford Craig SChief Legal, Compliance OfficeA - Grant$27.29+12,98630,765+73%+$354,3880-3+4+30
D
2009-09-15
CAHLaws Stuart GSVP, Chief Accounting OfficerA - Grant$27.29+2,86312,704+29%+$78,1310-3+4+30
D
2009-09-15
CAHKaufmann Michael CCEO, Pharmaceutical SegmentA - Grant$27.29+23,70164,620+58%+$646,8000-3+4+30
D
2009-09-15
CAHHenderson Jeffrey WilliamCFOA - Grant$27.29+29,626115,708+34%+$808,4940-3+4+30
D
2009-01-02
CAHHenderson Jeffrey WilliamCFOF - Tax$34.47-3,351115,708-3%-$115,5090-3+4+30
D
2009-09-15
CAHStephen Falk TEVP, Gen. Counsel, Corp. Sec.A - Grant$27.29+7,15622,629+46%+$195,2870-3+4+30
D
2009-09-15
CAHBarrett George SCOB, CEOA - Grant$27.29+156,468268,802+139%+$4,270,0120-3+4+30
D
2009-08-31
CAHFrancis Philip LDirD - Sale to issuer$0.00-1,7639,971-15%-$0+3+5+6+44
D
2009-08-31
CAHOhalleran Michael DFormer DirectorD - Sale to issuer$0.00-1,7638,458-17%-$0+3+5+6+44
D
2009-09-01
CAHLaws Stuart GSVP, Chief Accounting OfficerA - Grant$0.00+5469,841+6%+$0+3+5+6+44
D
2009-09-01
CAHNotebaert Richard CDirA - Grant$0.00+64416,965+4%+$0+3+5+6+44
D
2009-09-01
CAHWatkins Carole SCHROA - Grant$0.00+1,50544,782+3%+$0+3+5+6+44
D
2009-08-31
CAHSchlotterbeck David LFormer Vice Chair & CEO CTSD - Sale to issuer$0.00-17,28264,239-21%-$0+3+5+6+44
D
2009-08-31
CAHLosh J MichaelFormer DirectorD - Sale to issuer$0.00-1,7639,577-16%-$0+3+5+6+44
D
2009-09-01
CAHMorford Craig SChief Legal, Compliance OfficeA - Grant$0.00+2,55017,779+17%+$0+3+5+6+44
D
2009-09-01
CAHRaisbeck David WDirA - Grant$0.00+6446,365+11%+$0+3+5+6+44
D
2009-09-01
CAHSpaulding Jean GDirA - Grant$0.00+6443,030+27%+$0+3+5+6+44
D
2009-09-01
CAHLynch Michael ACEO, Medical SegmentA - Grant$0.00+1,61239,738+4%+$0+3+5+6+44
D
2009-09-01
CAHKenny Gregory BDirA - Grant$0.00+6442,856+29%+$0+3+5+6+44
D Derivative transaction exists (usually option exercise)
Open: Yahoo - Finviz - Stockcharts - Google

Return to top
S - SaleSale of securities on an exchange or to another person
S - Sale on exerciseSale of securities on an exchange or to another person (after option exercise)
F - OptEx/tax paymentPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person